Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

320.74
Delayed Data
As of Jun 23
 +0.63 / +0.20%
Today’s Change
240.30
Today|||52-Week Range
323.45
+20.86%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

How President Trump Has Sent Biotech Stocks Soaring
Jun 23 / TheStreet.com - Paid Partner Content
Healthcare Leads as Stocks Turn Higher After Release of Senate Bill
Jun 22 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: Price Momentum Needs to Stick Around
Jun 23 / TheStreet.com - Paid Partner Content
Stock Futures Dip as Crude Oil Looks to Correct Days-Long Slide
Jun 22 / TheStreet.com - Paid Partner Content
5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content

Performance

1 month+10.23% 3 years+8.41%
3 months+11.13% 5 years+20.23%
1 year+22.56% Since inception+7.52%
Data through 06/24/2017

Quote Details

Previous close$320.11
Open day’s range316.12 – 321.27
Net asset value (NAV)320.61 (06/23/2017)
Daily volume2,623,558
Average volume (3 months)1,146,803
Data as of 4:00pm ET, 06/23/2017

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+20.23%+16.30%
Expense Gross exp ratio0.47%1.33%
Risk 5 year sharpe ratio0.861.14
Net assets$7.7B$2.9B
Average market cap$16.4B$28.9B
Average P/E20.922.4
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
REGN Regeneron Pharmaceuticals7.97%
CELG Celgene7.66%
GILD Gilead Sciences7.61%
AMGN Amgen7.27%
BIIB Biogen7.10%
VRTX Vertex Pharmaceuticals Inc5.20%
ILMN Illumina Inc4.38%
INCY Incyte Corp4.02%
MYL Mylan NV3.53%
ALXN Alexion Pharmaceuticals Inc3.09%